{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:56:42Z","timestamp":1781643402025,"version":"3.54.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Center for Advancing Translational Sciences of the National Institutes of Health","award":["5KL2TR003981-04"],"award-info":[{"award-number":["5KL2TR003981-04"]}]},{"name":"University of Texas Southwestern Internal Medicine Pilot and Feasibility grant"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Sickle cell anemia (SCA) is associated with substantial end\u2011organ morbidity, yet the circulating microRNA (miRNA) landscape in clinically stable, comorbidity\u2011free adults with SCA is poorly defined. This pilot case-control study with a limited sample size aimed to characterize a baseline plasma miRNA signature of SCA by comparing comorbidity\u2011free adults with SCA and strictly matched controls, with findings intended to be hypothesis\u2011generating.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Using the Mass General Brigham Biobank, we identified 4 adults with HbSS SCA and 12 HbAA controls, matched 1:3 by age, sex, and estimated glomerular filtration rate. All participants were free of diabetes, hypertension, cardiovascular disease, chronic kidney disease, and proteinuria. Plasma small RNA sequencing identified 41 differentially expressed miRNAs in SCA versus controls (2 upregulated, 39 downregulated;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). These miRNAs mapped to 99 enriched KEGG pathways, including PI3K\/Akt, MAPK, and Hippo signaling, which are implicated in endothelial dysfunction, vasculopathy, and organ complications relevant to SCA. These preliminary, hypothesis\u2011generating findings from a small pilot cohort support the presence of subclinical vascular and inflammatory pathway dysregulation in comorbidity\u2011free SCA and provide candidate miRNAs and pathways for future validation in larger, independent cohorts. These results represent unvalidated discovery signals and should not be interpreted as a definitive miRNA profile.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13104-026-07765-y","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T17:57:31Z","timestamp":1773856651000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring plasma microRNA profiling and signaling pathways in comorbidity-free sickle cell anemia: a pilot case-control study"],"prefix":"10.1186","volume":"19","author":[{"given":"Kabir","family":"Olaniran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronak","family":"Lakhia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Krinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagar","family":"Nigwekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Hedayati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"7765_CR1","doi-asserted-by":"crossref","unstructured":"Piel F, Steinberg M, Rees D. Sickle Cell Disease. The New England journal of medicine 2017, 376.","DOI":"10.1056\/NEJMra1510865"},{"key":"7765_CR2","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","volume":"330","author":"OS Platt","year":"1994","unstructured":"Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994;330:1639\u201344.","journal-title":"N Engl J Med"},{"key":"7765_CR3","unstructured":"Williams TN, Thein SL. Sickle Cell Anemia and Its Phenotypes. In Annual Review of Genomics and Human Genetics, vol. 19. pp. annurev-genom-083117-021320: Annual Reviews 4139 El Camino Way, PO Box 10139, Palo Alto, California 94303-0139, USA; 2018:annurev-genom-083117-021320."},{"key":"7765_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41580-018-0059-1","volume":"20","author":"T Treiber","year":"2019","unstructured":"Treiber T, Treiber N, Meister G. Regulation of microRNA biogenesis and its crosstalk with other cellular pathways. Nat Rev Mol Cell Biol. 2019;20:5\u201320.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"7765_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00277-021-04665-y","volume":"101","author":"TP Biassi","year":"2022","unstructured":"Biassi TP, Guerra-Shinohara EM, Moretti PNS, de Freitas Dutra V, Caba\u00f1as-Pedro AC, Mecabo G, Colleoni GWB, Figueiredo MS. miRNA profile and disease severity in patients with sickle cell anemia. Ann Hematol. 2022;101:27\u201334.","journal-title":"Ann Hematol"},{"key":"7765_CR6","doi-asserted-by":"crossref","unstructured":"Cyrus C. The Role of miRNAs as Therapeutic Tools in Sickle Cell Disease. Med (Kaunas). 2021;57:1106.","DOI":"10.3390\/medicina57101106"},{"key":"7765_CR7","doi-asserted-by":"crossref","unstructured":"Karlson E, Boutin N, Hoffnagle A, Allen N. Building the Partners HealthCare Biobank at Partners Personalized Medicine: Informed Consent, Return of Research Results, Recruitment Lessons and Operational Considerations. In Journal of Personalized Medicine, vol. 6. p. 2; 2016:2.","DOI":"10.3390\/jpm6010002"},{"key":"7765_CR8","doi-asserted-by":"publisher","first-page":"336","DOI":"10.4172\/1948-5956.1000372","volume":"7","author":"S Ali","year":"2015","unstructured":"Ali S, Dubaybo H, Brand RE, Sarkar FH. Differential Expression of MicroRNAs in Tissues and Plasma Co-exists as a Biomarker for Pancreatic Cancer. J Cancer Sci Ther. 2015;7:336\u201346.","journal-title":"J Cancer Sci Ther"},{"key":"7765_CR9","doi-asserted-by":"publisher","first-page":"42498","DOI":"10.1038\/srep42498","volume":"7","author":"Z Lin","year":"2017","unstructured":"Lin Z, Ge J, Wang Z, Ren J, Wang X, Xiong H, Gao J, Zhang Y, Zhang Q. Let-7e modulates the inflammatory response in vascular endothelial cells through ceRNA crosstalk. Sci Rep. 2017;7:42498.","journal-title":"Sci Rep"},{"key":"7765_CR10","doi-asserted-by":"crossref","unstructured":"Eyileten C, Wicik Z, De Rosa S, Mirowska-Guzel D, Soplinska A, Indolfi C, Jastrzebska-Kurkowska I, Czlonkowska A, Postula M. MicroRNAs as Diagnostic and Prognostic Biomarkers in Ischemic Stroke-A Comprehensive Review and Bioinformatic Analysis. Cells 2018, 7.","DOI":"10.3390\/cells7120249"},{"key":"7765_CR11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13578-020-00436-w","volume":"10","author":"J Zhao","year":"2020","unstructured":"Zhao J, Zhou Y, Guo M, Yue D, Chen C, Liang G, Xu L. MicroRNA-7: expression and function in brain physiological and pathological processes. Cell Bioscience. 2020;10:77.","journal-title":"Cell Bioscience"},{"key":"7765_CR12","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s12872-024-03966-0","volume":"24","author":"Q Han","year":"2024","unstructured":"Han Q, Zhang L, Liao R. Diagnostic and prognostic significance of miR-320a-3p in patients with chronic heart failure. BMC Cardiovasc Disord. 2024;24:308.","journal-title":"BMC Cardiovasc Disord"},{"key":"7765_CR13","doi-asserted-by":"crossref","unstructured":"Zhang X, Dong S, Jia Q, Zhang A, Li Y, Zhu Y, Lv S, Zhang J. The microRNA in ventricular remodeling: the miR-30 family. Biosci Rep. 2019; 39:BSR20190788.","DOI":"10.1042\/BSR20190788"},{"key":"7765_CR14","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1002\/ehf2.13371","volume":"8","author":"A Galluzzo","year":"2021","unstructured":"Galluzzo A, Gallo S, Pardini B, Birolo G, Fariselli P, Boretto P, Vitacolonna A, Peraldo-Neia C, Spilinga M, Volpe A, et al. Identification of novel circulating microRNAs in advanced heart failure by next-generation sequencing. ESC Heart Fail. 2021;8:2907\u201319.","journal-title":"ESC Heart Fail"},{"key":"7765_CR15","first-page":"511","volume":"34","author":"WT Chang","year":"2018","unstructured":"Chang WT, Hsu CH, Huang TL, Tsai YC, Chiang CY, Chen ZC, Shih JY. MicroRNA-21 is Associated with the Severity of Right Ventricular Dysfunction in Patients with Hypoxia-Induced Pulmonary Hypertension. Acta Cardiol Sin. 2018;34:511\u20137.","journal-title":"Acta Cardiol Sin"},{"key":"7765_CR16","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1681\/ASN.2021010105","volume":"32","author":"E Satake","year":"2021","unstructured":"Satake E, Saulnier PJ, Kobayashi H, Gupta MK, Looker HC, Wilson JM, Md Dom ZI, Ihara K, O\u2019Neil K, Krolewski B, et al. Comprehensive Search for Novel Circulating miRNAs and Axon Guidance Pathway Proteins Associated with Risk of ESKD in Diabetes. J Am Soc Nephrol. 2021;32:2331\u201351.","journal-title":"J Am Soc Nephrol"},{"key":"7765_CR17","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/s41581-022-00608-6","volume":"18","author":"N Mahtal","year":"2022","unstructured":"Mahtal N, Lenoir O, Tinel C, Anglicheau D, Tharaux P-L. MicroRNAs in kidney injury and disease. Nat Rev Nephrol. 2022;18:643\u201362.","journal-title":"Nat Rev Nephrol"},{"key":"7765_CR18","doi-asserted-by":"crossref","unstructured":"Ataga KI, Saraf SL, Derebail VK. The nephropathy of sickle cell trait and sickle cell disease. Nat Rev Nephrol 2022;18:361-77.","DOI":"10.1038\/s41581-022-00540-9"},{"key":"7765_CR19","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1681\/ASN.2019050502","volume":"31","author":"KO Olaniran","year":"2020","unstructured":"Olaniran KO, Allegretti AS, Zhao SH, Achebe MM, Eneanya ND, Thadhani RI, Nigwekar SU, Kalim S. Kidney Function Decline among Black Patients with Sickle Cell Trait and Sickle Cell Disease: An Observational Cohort Study. J Am Soc Nephrol. 2020;31:393\u2013404.","journal-title":"J Am Soc Nephrol"},{"key":"7765_CR20","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.03.023","volume":"25","author":"W He","year":"2016","unstructured":"He W, Chen S, Chen X, Li S, Chen W. Bioinformatic Analysis of Potential microRNAs in Ischemic Stroke. J Stroke Cerebrovasc Dis. 2016;25:1753\u20139.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"7765_CR21","doi-asserted-by":"publisher","first-page":"118830","DOI":"10.1016\/j.lfs.2020.118830","volume":"265","author":"K Zhang","year":"2021","unstructured":"Zhang K, Qin X, Wen P, Wu Y, Zhuang J. Systematic analysis of molecular mechanisms of heart failure through the pathway and network-based approach. Life Sci. 2021;265:118830.","journal-title":"Life Sci"},{"key":"7765_CR22","doi-asserted-by":"crossref","unstructured":"Wei RQ, Zhang WM, Liang Z, Piao C, Zhu G. Identification of Signal Pathways and Hub Genes of Pulmonary Arterial Hypertension by Bioinformatic Analysis. Can Respir J. 2022; 2022:1394088.","DOI":"10.1155\/2022\/1394088"},{"key":"7765_CR23","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41392-022-01036-5","volume":"7","author":"Q Yuan","year":"2022","unstructured":"Yuan Q, Tang B, Zhang C. Signaling pathways of chronic kidney diseases, implications for therapeutics. Signal Transduct Target Ther. 2022;7:182.","journal-title":"Signal Transduct Target Ther"},{"key":"7765_CR24","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3389\/fmed.2017.00259","volume":"4","author":"W Li","year":"2017","unstructured":"Li W, Zhao Y, Fu P. Hypoxia Induced Factor in Chronic Kidney Disease: Friend or Foe? Front Med (Lausanne). 2017;4:259.","journal-title":"Front Med (Lausanne)"},{"key":"7765_CR25","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1097\/MNH.0000000000000616","volume":"29","author":"F Lin","year":"2020","unstructured":"Lin F. Molecular regulation and function of FoxO3 in chronic kidney disease. Curr Opin Nephrol Hypertens. 2020;29:439\u201345.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"7765_CR26","doi-asserted-by":"publisher","first-page":"F1","DOI":"10.1152\/ajprenal.00244.2002","volume":"285","author":"R Debigar\u00e9","year":"2003","unstructured":"Debigar\u00e9 R, Price SR. Proteolysis, the ubiquitin-proteasome system, and renal diseases. Am J Physiology-Renal Physiol. 2003;285:F1\u20138.","journal-title":"Am J Physiology-Renal Physiol"},{"key":"7765_CR27","doi-asserted-by":"crossref","unstructured":"Ning B, Guo C, Kong A, Li K, Xie Y, Shi H, Gu J. Calcium Signaling Mediates Cell Death and Crosstalk with Autophagy in Kidney Disease. Cells 2021, 10.","DOI":"10.3390\/cells10113204"},{"key":"7765_CR28","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41598-022-25444-3","volume":"13","author":"N Kargutkar","year":"2023","unstructured":"Kargutkar N, Sawant-Mulay M, Hariharan P, Chandrakala S, Nadkarni A. Role of microRNA in hydroxyurea mediated HbF induction in sickle cell anaemia patients. Sci Rep. 2023;13:369.","journal-title":"Sci Rep"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-026-07765-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-026-07765-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-026-07765-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:26:02Z","timestamp":1781641562000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13104-026-07765-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7765"],"URL":"https:\/\/doi.org\/10.1186\/s13104-026-07765-y","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"assertion":[{"value":"11 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Biospecimens and clinical data were obtained from the Mass General Brigham Biobank, which enrolls participants under institutional review board\u2013approved protocols with written informed consent for banking and future research use of samples and linked electronic health record data. Use of de\u2011identified Mass General Brigham Biobank data and plasma samples for this study was approved by the Mass General Brigham and University of Texas Southwestern (UTSW) institutional review boards under UTSW IRB #STU\u20112020\u20111053. All procedures were conducted in accordance with the Declaration of Helsinki and relevant institutional guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"189"}}